PT Merck Sharp & Dohme Indonesia

PT Merck Sharp & Dohme Indonesia, established in 1972, operates as a prominent pharmaceutical entity within the Asian healthcare sector. The organization maintains a robust operational footprint with one primary location in Jakarta, Indonesia, focusing on the development, manufacturing, and distribution of advanced medical solutions. With a workforce ranging from 1,000-5,000 employees, the company integrates specialized departments including finance, medical services, and strategic marketing to drive healthcare innovation across the region.

The firm’s product portfolio is centered on high-impact pharmaceutical offerings, including antimicrobial agents and specialized medical treatments designed to address complex health conditions. By leveraging its position as a key player in the Indonesian market, PT Merck Sharp & Dohme Indonesia ensures the consistent delivery of therapeutic products that meet rigorous industry standards. The company’s operational model emphasizes technical excellence in pharmaceutical manufacturing and supply chain management to support local and regional health infrastructure requirements.

Organizational success is driven by a dedicated professional staff committed to advancing medical science and patient outcomes. Meet PT Merck Sharp & Dohme Indonesia's team to understand the leadership and operational expertise guiding these initiatives. Through its strategic focus on medical and health services, the company continues to expand its influence in the pharmaceutical industry, maintaining a strong commitment to quality and innovation in every aspect of its business operations and product development lifecycle.